ELL Antikörper (AA 1-407) (HRP)
Kurzübersicht für ELL Antikörper (AA 1-407) (HRP) (ABIN7987372)
Target
Alle ELL Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-407
-
Verwendungszweck
- Anti-ELL Antibody HRP Conjugated
-
Kreuzreaktivität (Details)
- No cross-reactivity with other proteins.
-
Aufreinigung
- Immunogen affinity purified.
-
Immunogen
- E.coli-derived human ELL recombinant protein (Position: M1-S407).
-
Isotyp
- IgG
-
-
anti-Elongation Factor RNA Polymerase II (ELL) antibody
ELL Reaktivität: Human WB, FACS Wirt: Maus Monoclonal 24GB8330 unconjugated
anti-Elongation Factor RNA Polymerase II (ELL) (AA 551-600) antibodyELL Reaktivität: Human, Maus, Hund, Ratte, Rind (Kuh), Pferd, Zebrafisch (Danio rerio), Affe WB, IHC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Elongation Factor RNA Polymerase II (ELL) (N-Term) antibodyELL Reaktivität: Human, Affe WB, IHC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Elongation Factor RNA Polymerase II (ELL) (AA 1-407) antibodyELL Reaktivität: Human WB, ELISA, FACS, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Elongation Factor RNA Polymerase II (ELL) (AA 522-619) antibodyELL Reaktivität: Human WB, ELISA Wirt: Maus Polyclonal unconjugated
anti-Elongation Factor RNA Polymerase II (ELL) (AA 516-545), (C-Term) antibodyELL Reaktivität: Human, Maus WB Wirt: Kaninchen Polyclonal RB23401 unconjugated
anti-Elongation Factor RNA Polymerase II (ELL) (AA 431-480) antibodyELL Reaktivität: Human, Hund WB Wirt: Kaninchen Polyclonal unconjugated
anti-Elongation Factor RNA Polymerase II (ELL) antibodyELL Reaktivität: Human WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Elongation Factor RNA Polymerase II (ELL) (AA 350-450) antibodyELL Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Elongation Factor RNA Polymerase II (ELL) (N-Term) antibodyELL Reaktivität: Human, Maus, Hund, Ratte, Rind (Kuh), Meerschweinchen WB, IHC Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- Western blot, Optimal dilutions should be determined by end users. Immunohistochemistry (Paraffin-embedded Section), Optimal dilutions should be determined by end users. ELISA, Optimal dilutions should be determined by end users.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing.
-
Haltbarkeit
- 12 months
-
-
- ELL (Elongation Factor RNA Polymerase II (ELL))
-
Andere Bezeichnung
- ELL
-
Hintergrund
-
Background: RNA polymerase II elongation factor ELL is an enzyme that in humans is encoded by the ELL gene. Eleven-nineteen lysine-rich leukemia protein (ELL) was originally identified in a screen for genes that fuse to MLL (myeloid-lymphoid leukemia) in the t(11,19)(q23,p13.1) breakpoint. ELL is an elongation factor that increases the catalytic rate of RNA pol II by suppressing transient pausing of RNA pol II. ELL has been shown to be essential to development and important to cell growth and survival. Alternate names for ELL include RNA polymerase II elongation factor ELL, ELL1, and men.
Gene Full Name: elongation factor for RNA polymerase II
-
Gen-ID
- 8178
-
UniProt
- P55199
Target
-
